CB1 activation is associated with endothelial dysfunction and atherosclerosis (El‐Remessy et al, 2011; Rajesh et al, 2012), whereas CB2 activation is related to vascular quiescence (Pacher & Mackie, 2012; Pacher et al, 2018). Here, CNR1 is linked to endothelial dysfunction.